Standout Papers

Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic M... 1997 2026 2006 2016 2.1k
  1. Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF (2004)
    Paul Wan, Mathew J. Garnett et al. Cell
  2. Identification and Structural Characterization of the ATP/ADP-Binding Site in the Hsp90 Molecular Chaperone (1997)
    Chrisostomos Prodromou, S. Mark Roe et al. Cell
  3. Structural Basis for Inhibition of the Hsp90 Molecular Chaperone by the Antitumor Antibiotics Radicicol and Geldanamycin (1999)
    S. Mark Roe, Chrisostomos Prodromou et al. Journal of Medicinal Chemistry
  4. Crystal structure of an Hsp90–nucleotide–p23/Sba1 closed chaperone complex (2006)
    Maruf M. U. Ali, S. Mark Roe et al. Nature
  5. GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins (2003)
    Laurent Meijer, Alexios-Leandros Skaltsounis et al. Chemistry & Biology
  6. Crystal Structure of Glycogen Synthase Kinase 3β (2001)
    Rana Dajani, Elizabeth Fraser et al. Cell

Immediate Impact

11 by Nobel laureates 34 from Science/Nature 96 standout
Sub-graph 1 of 16

Citing Papers

Metazoan MicroRNAs
2018 Standout
AKT/PKB Signaling: Navigating the Network
2017 Standout
25 intermediate papers

Works of S. Mark Roe being referenced

Structural insights into mRNA recognition from a PIWI domain–siRNA guide complex
2005 Nature
Crystal Structure of Glycogen Synthase Kinase 3β
2001 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
S. Mark Roe 9782 1423 557 1545 126 12.4k
Robert A. Copeland 6873 1200 102 1676 156 10.6k
Michelle R. Arkin 6532 1697 121 1700 137 9.6k
Gabriela Chiosis 7523 924 48 992 182 10.0k
L.N. Johnson 9187 2430 104 1819 169 12.6k
Maurizio Pellecchia 7568 1104 41 1891 201 10.8k
Edward T. Olejniczak 7725 1065 99 1452 122 10.6k
Ronald E. Stenkamp 8654 840 1015 1036 144 12.9k
David W. Banner 4118 2144 530 736 102 9.0k
Richard A. Engh 4977 796 287 1253 98 7.9k
Chung‐Jung Tsai 8557 374 26 821 132 10.2k

All Works

Loading papers...

Rankless by CCL
2026